Tissue polypeptide-specific antigen and carcinoembryonic antigen for early prediction of recurrence in lung adenocarcinoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 23, Issue 6, 2000, Pages 605-608

  Sun, Shung Shung ^a,b,c,d,e   Hsieh, Jih Fang ^a,b,c,d,e   Tsai, Shih Chuan ^a,b,c,d,e   Ho, Yung Jen ^a,b,c,d,e   Kao, Chia Hung ^a,b,c,d,e  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHI MEI FOUNDATION HOSPITAL   (Taiwan)

^c SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^d JEN AI HOSPITAL   (Taiwan)

^e TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Carcinoembryonic antigen; Lung adenocarcinoma; Tissue polypeptide specific antigen

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG ADENOCARCINOMA; MALE; MEASUREMENT; POSTOPERATIVE PERIOD; PREDICTION; PROTEIN BLOOD LEVEL;

ADENOCARCINOMA; ADULT; AGED; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PEPTIDES; TUMOR MARKERS, BIOLOGICAL;

EID: 0034443893     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200012000-00016     Document Type: Article

References (21)

1. Comparison studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma
2. Squamous cell carcinoma antigen as an adjunct tumour marker in primary carcinoma of the lung
3. Antigenicity of pooled human malignant and normal tissue by cytoimmunological technique: Presence of an insoluble heat-labile tumor antigen
4. Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and tissue polypeptide specific antigen (TPS) as tumour markers in lung cancer
5. A new international staging system for lung cancer
6. The use of nitrogen mustards in the palliative treatment of carcinoma with particular reference to bronchogenic carcinoma
7. Prognosis and end results
8. Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer
9. Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinoma
10. Preoperative carcinoembryonic antigen and survival after resection of lung cancer
11. Correlation of cell proliferation marker (TPS), natural killer (NK) activity and tumor load serotest (PSA) in untreated and treated prostatic tumors
12. Prognostic significance of tissue polypeptide-specific antigen (TPS) in patients with advanced non-small cell lung cancer
13. Clinical evaluation of serum tissue polypeptide-specific antigen (TPS) in non-small cell lung cancer
14. Tissue polypeptide specific antigen (TPS) in breast cancer - An initial evaluation
15. Determination of serum tumor markers TPS and CA 15-3 during monitoring of treatment in metastatic breast cancer patients
16. TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patients
17. Clinical value of TPS, CEA and CA 15-3 in breast cancer patients
18. Tissue polypeptide specific antigen for early prediction of non-small cell lung cancer recurrence
19. Evaluation of tissue polypeptide specific antigen, CYRFA 21-1, and carcinomembryonic antigen in nonsmall cell lung carcinoma
20. Squamous cell carcinoma antigen (SCC Ag) in the diagnosis and prognosis of lung cancer